@Southoz
re "That agreement was changed. And the new agreement was announced in the 3rd quarter financial."
So, if the agreement was changed as recently as this year, what did Teva mean when they said the following? Which "contractual right" were they referring to if there is a now a new one in operation and where is the new agreement?
"Teva confirms that it has exercised its contractual right to terminate its involvement in the Phase 3 clinical trial of CEP-41750 (mesenchymal precursor cell) for chronic heart failure"
Ann: First Quarter Results On Form 6K, page-116
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.31 |
Change
-0.010(0.76%) |
Mkt cap ! $1.495B | |||
| Open | High | Low | Value | Volume |
| $1.31 | $1.33 | $1.28 | $1.819M | 1.396M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 29972 | $1.31 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.31 | 2008 | 1 |
View Market Depth
| Last trade - 16.10pm 01/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |